 Intercept Pharmaceuticals Inc NASDAQ:ICPT Investment analysts at Wedbush raised their Q3 2020 EPS estimates for shares of Intercept Pharmaceuticals in a research report issued to clients and investors on Monday, August 24th. Wedbush analyst L. Moussatos now forecasts that the biopharmaceutical company will earn 2.13 per share for the quarter, up from their prior ... 